Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|July 29, 2021
M2-Deficient Single-Replication Influenza Vaccine-Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza StrainJoseph Eiden, Bram Volckaert, Oleg Rudenko, et al.
Vaccine|February 5, 2016
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adultsLars Ostergaard, Gregg H Lucksinger, Judith Absalon, et al.
Human Vaccines & Immunotherapeutics|August 8, 2018
Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adultsMegumi Inoue, Takuma Yonemura, James Baber, et al.
Vaccine|February 2, 2017
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodiesElizabeth Begier, David Joshua Seiden, Michael Patton, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2006
Modulation of immunogenicity and allergenicity by controlling the number of immunostimulatory oligonucleotides linked to Amb a 1Deborah Higgins, Roberto Rodriguez, Robert Milley, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B DiseaseGary W Zlotnick, Thomas R Jones, Paul Liberator, et al.
Journal of the Pediatric Infectious Diseases Society|January 25, 2016
Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy AdolescentsTimo Vesikari, Jacek Wysocki, Johannes Beeslaar, et al.
Vaccines|December 28, 2021
Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in AdultsJoseph Eiden, Gilad Gordon, Carlos Fierro, et al.
The Journal of Infection|August 14, 2016
Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 studyHelen Marshall, Michael Nissen, Peter Richmond, et al.
The Journal of Infection|October 5, 2019
S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccineHelen S Marshall, James Baber, Peter Richmond, et al.
Pageof 4